Published in Can J Physiol Pharmacol on February 01, 1980
Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest (1997) 2.16
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest (1994) 2.09
Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. J Clin Invest (1991) 1.22
Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. J Clin Invest (1987) 1.13
Regulatory processes interacting to maintain hepatic blood flow constancy: Vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol Res (2007) 1.10
Direct muscarinic cholinergic inhibition of hepatic glucose production in humans. J Clin Invest (1988) 0.85
Gastric afferents project to the aldosterone-sensitive HSD2 neurons of the NTS. Brain Res (2009) 0.82
Disappearance of hepatic parenchymal nerves in human liver cirrhosis. Gut (1992) 0.82
Preserved arterial flow secures hepatic oxygenation during haemorrhage in the pig. J Physiol (1999) 0.79
Regulation of hepatic function by brain neuropeptides. World J Gastroenterol (1998) 0.77
Control of glycogenolysis and blood flow by arterial and portal adrenaline in perfused liver. Biochem J (1991) 0.75
Cardiopulmonary and sinoaortic baroreceptors and volume expansion in the monkey. Basic Res Cardiol (1986) 0.75
Circadian rhythm of protein C in human plasma--useful marker of autonomic function in liver. Clin Auton Res (2005) 0.75
Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol (1985) 1.91
Adenosine as putative regulator of hepatic arterial flow (the buffer response). Am J Physiol (1985) 1.30
Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response. Fed Proc (1983) 1.21
Improved high-pressure liquid chromatographic-fluorometric assay for measurement of adenosine in plasma. Am J Physiol (1991) 1.11
Effects of infusions of catecholamines, angiotensin, vasopressin and histamine on hepatic blood volume in the anaesthetized cat. Br J Pharmacol (1972) 1.09
The use of 8-phenyltheophylline as a competitive antagonist of adenosine and an inhibitor of the intrinsic regulatory mechanism of the hepatic artery. Can J Physiol Pharmacol (1985) 1.08
Effects of hepatic venous pressure on transsinusoidal fluid transfer in the liver of the anesthetized cat. Circ Res (1970) 1.07
Hepatic arterial pressure-flow autoregulation is adenosine mediated. Am J Physiol (1987) 1.07
Separation of acute and delayed hemodynamic responses to endotoxin in the cat. Am J Physiol (1969) 1.05
Capacitance responses and fluid exchange in the cat liver during stimulation of the hepatic nerves. Circ Res (1969) 1.01
Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide (2001) 0.99
Afferent and efferent neural roles in liver function. Prog Neurobiol (1983) 0.99
Blood volume, the venous system, preload, and cardiac output. Can J Physiol Pharmacol (1986) 0.97
Evidence of nitric oxide, a flow-dependent factor, being a trigger of liver regeneration in rats. Can J Physiol Pharmacol (1998) 0.96
Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia (2005) 0.94
Control of hepatic arterial blood flow: independence from liver metabolic activity. Am J Physiol (1980) 0.92
Blockade of hepatic nitric oxide synthase causes insulin resistance. Am J Physiol (1999) 0.91
Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. Am J Physiol (1996) 0.91
Hepatic parasympathetic neural effect on glucose balance in the intact liver. Can J Physiol Pharmacol (1978) 0.90
The comparative effect of administration of substances via the hepatic artery or portal vein on hepatic arterial resistance, liver blood volume and hepatic extraction in cats. Hepatology (1984) 0.90
Active and passive control of hepatic blood volume responses to hemorrhage at normal and raised hepatic venous pressure in cats. Can J Physiol Pharmacol (1980) 0.88
Hepatic venous compliance and role of liver as a blood reservoir. Am J Physiol (1976) 0.88
Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am J Physiol (1996) 0.88
Effects of adrenaline, isoprenaline and histamine on transsinusoidal fluid filtration in the cat liver. Br J Pharmacol (1972) 0.86
Nitric oxide mediates hepatic arterial vascular escape from norepinephrine-induced constriction. Am J Physiol (1999) 0.84
Localization of intrahepatic portal vascular resistance. Am J Physiol (1986) 0.83
Shear-induced modulation of vasoconstriction in the hepatic artery and portal vein by nitric oxide. Am J Physiol (1998) 0.83
Effects of acute, passive hepatic congestion on blood flow and oxygen uptake in the intact liver of the cat. Circ Res (1977) 0.83
Induction of insulin resistance by cholinergic blockade with atropine in the cat. J Auton Pharmacol (1995) 0.82
Distensibility of hepatic venous resistance sites and consequences on portal pressure. Am J Physiol (1988) 0.82
The hepatic artery: subservient to hepatic metabolism or guardian of normal hepatic clearance rates of humoral substances. Gen Pharmacol (1977) 0.82
Hepatocyte primary culture bioassay: a simplified tool to assess the initiation of the liver regeneration cascade. J Pharmacol Toxicol Methods (1997) 0.81
Autoregulation of superior mesenteric artery is blocked by adenosine antagonism. Can J Physiol Pharmacol (1986) 0.81
Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration. Proc West Pharmacol Soc (2000) 0.81
Capacitance responses and fluid exchange in the cat liver. J Physiol (1969) 0.81
Effect of hepatic nerves, norepinephrine, angiotensin, and elevated central venous pressure on postsinusoidal resistance sites and intrahepatic pressures in cats. Microvasc Res (1987) 0.81
Method for measuring hepatic uptake of oxygen or other blood-borne substances in situ. J Appl Physiol (1976) 0.81
Hepatic vasculature: a conceptual review. Gastroenterology (1977) 0.81
Effect of histamine, norepinephrine, and nerves on vascular pressures in dog liver. Am J Physiol (1987) 0.80
Nitric oxide inhibits norepinephrine-induced hepatic vascular responses but potentiates hepatic glucose output. Can J Physiol Pharmacol (2000) 0.80
Release and regulation of endogenous adenosine during hemorrhage. Pharmacology (1994) 0.80
A characterization of gamma-glutamyltranspeptidase in normal, perinatal, premalignant and malignant rat liver. Int J Biochem (1987) 0.80
Does nitric oxide (NO) trigger liver regeneration? Proc West Pharmacol Soc (1997) 0.80
Intrahepatic adenosine triggers a hepatorenal reflex to regulate renal sodium and water excretion. Auton Neurosci (2001) 0.79
Evaluation of topical phenol as a means of producing autonomic denervation of the liver. Can J Physiol Pharmacol (1984) 0.79
Hepatic venous resistance site in the dog: localization and validation of intrahepatic pressure measurements. Can J Physiol Pharmacol (1987) 0.79
Insulin sensitivity tested with a modified euglycemic technique in cats and rats. J Pharmacol Toxicol Methods (1996) 0.79
Nitric oxide suppression of norepinephrine release from nerves in the superior mesenteric artery. Proc West Pharmacol Soc (1994) 0.79
Hepatic blood volume responses and compliance in cats with long-term bile duct ligation. Hepatology (1993) 0.79
Hepatic presinusoidal sphincters affected by altered arterial pressure and flow, venous pressure, and nerve stimulation. Microvasc Res (1978) 0.79
Autonomic neural control of liver glycogen metabolism. Med Hypotheses (1979) 0.79
Adenosine modulation of hepatic arterial but not portal venous constriction induced by sympathetic nerves, norepinephrine, angiotensin, and vasopressin in the cat. Can J Physiol Pharmacol (1986) 0.79
Expression of vascular escape: conductance or resistance? Am J Physiol (1992) 0.79
Hepatic parasympathetic neuropathy as cause of maturity-onset diabetes? Gen Pharmacol (1980) 0.78
Insulin resistance produced by hepatic denervation or muscarinic cholinergic blockade. Proc West Pharmacol Soc (1994) 0.78
M1 muscarinic receptor blockade causes insulin resistance in the cat. Proc West Pharmacol Soc (1995) 0.78
Insulin resistance caused by nitric oxide synthase inhibition. Proc West Pharmacol Soc (1997) 0.78
iNOS is not involved in shear stress-induced nitric oxide release, which triggers the liver regeneration cascade. Proc West Pharmacol Soc (2001) 0.78
Blockade of nitric oxide production in the liver causes insulin resistance. Proc West Pharmacol Soc (1998) 0.78
Differential effect of taurocholic acid on hepatic arterial resistance vessels and bile flow. Am J Physiol (1983) 0.78
Hepatic capacitance vessel responses to bilateral carotid occlusion in anesthetized cats. Can J Physiol Pharmacol (1972) 0.78
Hepatic blood flow: estimation from clearances of very low dose infusions of ethanol in cats. Can J Physiol Pharmacol (1988) 0.78
Potentiation to vasodilators by nitric oxide synthase blockade in superior mesenteric but not hepatic artery. Am J Physiol (1997) 0.78
Insulin resistance of glucose response produced by hepatic denervations. Can J Physiol Pharmacol (1993) 0.78
Hemodynamic effects of CCl4 in the intact liver of the cat. Can J Physiol Pharmacol (1974) 0.77
The effect of 6-hydroxydopamine-induced hepatic sympathectomy on the early hyperglycemic response to surgical trauma under anesthesia. J Trauma (1977) 0.77
Acute and chronic ethanol on hepatic oxygen ethanol and lactate metabolism in cats. Am J Physiol (1990) 0.77
Evaluation of surgical denervation of the liver in cats. Can J Physiol Pharmacol (1981) 0.77
Effect of nerve stimulation on percapillary sphincters, oxygen extraction, and hemodynamics in the intestines of cats. Circ Res (1977) 0.77
The effect of hypertonic infusions on hepatic blood flows and liver volume in the cat. Can J Physiol Pharmacol (1977) 0.77
Effect of stimulation of hepatic nerves on hepatic O2 uptake and blood flow. Am J Physiol (1977) 0.76
Control of hepatic and intestinal blood flow: effect of isovolaemic haemodilution on blood flow and oxygen uptake in the intact liver and intestines. J Physiol (1977) 0.76
Glucose disposal by insulin, but not IGF-1, is dependent on the hepatic parasympathetic nerves. Can J Physiol Pharmacol (2000) 0.76
Shear-induced modulation by nitric oxide of sympathetic nerves in the superior mesenteric artery. Can J Physiol Pharmacol (1996) 0.76
Blood flow-dependent prostaglandin f(2alpha) regulates intestinal glucose uptake from the blood. Am J Physiol (1999) 0.75
Autoregulatory capacity in the superior mesenteric artery is attenuated by nitric oxide. Am J Physiol (1996) 0.75
Measurement of hepatic blood flow from ethanol clearance in anesthetized cats. Hepatology (1990) 0.75
Arterial and venous plasma concentrations of adenosine during haemorrhage. Br J Pharmacol (1992) 0.75
The effects of linsidomine on portal hypertension. Hepatology (1992) 0.75
Insulin and glucagon response during hemorrhage induced hyperglycemia. Can J Physiol Pharmacol (1982) 0.75
Carotid sinus baroreceptor effects on cat livers in control and hemorrhaged states. Can J Physiol Pharmacol (1982) 0.75
Control of the hyperglycemic response to hemorrhage in cats. Can J Physiol Pharmacol (1982) 0.75
Adenosine metabolism in vivo. Proc West Pharmacol Soc (1994) 0.75
Effect of hepatic nerve stimulation on hepatic uptake of lidocaine in the cat. Life Sci (1976) 0.75
Dynamic control of the release of a hepatic insulin-sensitizing substance. Proc West Pharmacol Soc (1999) 0.75
An intracaval cannulation for obtaining pure, mixed hepatic venous blood samples. Am J Physiol (1978) 0.75
Development of portacaval shunts in portal-stenotic cats. Can J Physiol Pharmacol (1993) 0.75
Shear-induced release of nitric oxide antagonizes adenosine effects on intestine metabolism. Proc West Pharmacol Soc (1998) 0.75
Effects of the liver on circulating adenosine in blood. Can J Physiol Pharmacol (1993) 0.75
Hepatic glucose balance in response to direct stimulation of sympathetic nerves in the intact liver of cats. Can J Physiol Pharmacol (1978) 0.75
Neural activation of alpha-adrenoreceptors in glucose mobilization from liver. Can J Physiol Pharmacol (1979) 0.75
Distensibility of portacaval shunts in portal hypertensive cats: index of contractility model. Can J Physiol Pharmacol (1994) 0.75
Fetal exposure to alcohol results in adult insulin resistance in the rat. Proc West Pharmacol Soc (1998) 0.75
Blockade of nitric oxide synthase potentiates the suppression of vasodilators by norepinephrine in the hepatic artery. Nitric Oxide (1999) 0.75
Nitric oxide synthase antagonism potentiates pressure-flow autoregulation in the superior mesenteric artery. Proc West Pharmacol Soc (1995) 0.75
Letter: Splanchnic hemodynamic response to passive hyperventilation. J Appl Physiol (1975) 0.75
The effect of SKF-525A and of altered hepatic blood flow on lidocaine clearance in the cat. Can J Physiol Pharmacol (1977) 0.75
Evaluation of vascular tone in portacaval shunts comparing the index of contractility and resistance in cats. Hepatology (1994) 0.75
Effect of raised portal venous pressure and postocclusive hyperemia on superior mesenteric arterial resistance in control and adenosine receptor blocked state in cats. Can J Physiol Pharmacol (1986) 0.75
Shear stress-induced nitric oxide antagonizes adenosine effects on intestinal metabolism. Am J Physiol (1999) 0.75